CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 157 enrolled
Drug / intervention
Nicotine Patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01208935
NCT01208935Phase 3Completed
CompareCT.gov

Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence

National Institute on Drug Abuse (NIDA)·interventional·Posted Sep 24, 2010·Updated Jan 12, 2017

In Brief

A Phase 3 clinical trial evaluating Nicotine Patch and Nicotine Gum for Tobacco Dependence. Completed, enrolled 157 participants across 1 site.

Detailed Summary

The purpose of this study is to test the safety, tolerability, compliance and efficacy of two different forms of nicotine replacement therapy (NRT) (the nicotine transdermal patch and the nicotine gum) in a nicotine-dependent adolescent population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Dependence
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 24, 2010
Enrollment StartAug 1, 1999
Primary CompletionJun 1, 2004
Study CompletionAug 1, 2004
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 15.8 years ago

Interventions

Nicotine Patchdrug

Nicotine Gumdrug